Eric Bruckert Selected Research

Eric Bruckert Research Topics

Disease

39	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 03/2003
38	Atherosclerosis 03/2024 - 03/2002
30	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2023 - 06/2003
15	Hypercholesterolemia 10/2023 - 03/2002
15	Dyslipidemias (Dyslipidemia) 09/2023 - 08/2003
15	Homozygous Familial Hypercholesterolemia 07/2023 - 05/2002
14	Stroke (Strokes) 01/2023 - 01/2006
11	Pancreatitis 09/2023 - 07/2008
11	Ischemic Stroke 01/2023 - 05/2014
11	Coronary Disease (Coronary Heart Disease) 12/2021 - 06/2003
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018 - 10/2004
9	Insulin Resistance 09/2011 - 05/2002
8	Hypertriglyceridemia 08/2023 - 01/2003
7	Atherosclerotic Plaque (Atheroma) 01/2023 - 01/2003
7	Myocardial Infarction 12/2022 - 02/2004
7	Inflammation (Inflammations) 12/2021 - 02/2004
6	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 03/2008
6	Transient Ischemic Attack 01/2023 - 05/2014
5	Hypertension (High Blood Pressure) 01/2022 - 09/2002
5	Myalgia 01/2021 - 09/2003
5	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2012
5	Acute Coronary Syndrome 12/2020 - 01/2003
5	Inborn Genetic Diseases (Disease, Hereditary) 05/2020 - 03/2015
5	Abdominal Obesity 07/2018 - 10/2004
4	Prediabetic State (Prediabetes) 01/2021 - 09/2011
4	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 10/2020 - 11/2002
4	Xanthomatosis (Xanthoma) 01/2019 - 12/2013
4	Hyperlipidemias (Hyperlipidemia) 02/2017 - 08/2003
4	Fibrosis (Cirrhosis) 10/2014 - 02/2004
3	Pathologic Constriction (Stenosis) 01/2023 - 01/2020
3	Chronic Renal Insufficiency 10/2021 - 03/2014
3	Muscular Diseases (Myopathy) 01/2021 - 05/2015
3	Costello Syndrome 10/2020 - 01/2018
3	Carotid Artery Diseases 01/2020 - 03/2009
3	Neoplasms (Cancer) 12/2015 - 02/2004
3	Obesity 10/2014 - 05/2002
3	Fatty Liver 10/2014 - 07/2008
2	Cerebral Infarction 12/2022 - 10/2016
2	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2022 - 05/2015
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022 - 01/2020
2	Infections 10/2021 - 01/2019
2	Body Weight (Weight, Body) 05/2020 - 11/2017
2	Overweight 07/2018 - 03/2004
2	Diabetes Mellitus 01/2018 - 02/2011
2	Non-alcoholic Fatty Liver Disease 02/2010 - 07/2008
2	Rupture 07/2003 - 01/2003
1	Vascular Diseases (Vascular Disease) 01/2023
1	Peripheral Arterial Disease 12/2022

Drug/Important Bio-Agent (IBA)

56	oxidized low density lipoproteinIBA 03/2024 - 03/2002
53	LDL CholesterolIBA 03/2024 - 06/2003
48	LipidsIBA 03/2024 - 03/2002
32	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 05/2002
30	CholesterolIBA 01/2023 - 05/2002
28	Triglycerides (Triacylglycerol)IBA 09/2023 - 01/2003
21	Lipoproteins (Lipoprotein)IBA 01/2021 - 08/2003
18	HDL CholesterolIBA 05/2023 - 11/2003
13	ApolipoproteinsIBA 01/2020 - 06/2003
9	Apolipoproteins B (ApoB)IBA 01/2020 - 06/2003
9	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020 - 10/2004
8	LDL Receptors (LDL Receptor)IBA 09/2023 - 06/2003
8	Proprotein Convertase 9IBA 09/2023 - 06/2003
8	Ezetimibe (Zetia)FDA Link 01/2023 - 05/2002
8	Biomarkers (Surrogate Marker)IBA 09/2019 - 04/2006
7	HDL LipoproteinsIBA 05/2023 - 08/2003
7	alirocumabIBA 12/2022 - 12/2015
5	CalciumIBA 01/2023 - 07/2018
5	Lipoprotein(a)IBA 12/2021 - 08/2012
5	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 06/2004
5	Phytosterols (Plant Sterols)IBA 01/2018 - 09/2007
5	Cholesterol Esters (Cholesteryl Esters)IBA 03/2008 - 03/2002
4	Apolipoprotein A-I (Apolipoprotein A1)IBA 10/2020 - 11/2006
4	Atorvastatin (Lipitor)FDA Link 09/2019 - 05/2002
4	Proteins (Proteins, Gene)FDA Link 07/2018 - 08/2003
4	Insulin (Novolin)FDA Link 07/2008 - 05/2002
3	Apolipoproteins E (ApoE)IBA 05/2022 - 12/2011
3	BMS201038IBA 01/2021 - 08/2014
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2020 - 12/2005
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2019 - 01/2003
3	Fibric Acids (Fibrates)IBA 02/2011 - 08/2003
3	C-Reactive ProteinIBA 07/2008 - 06/2006
2	Phospholipids (Phosphatides)FDA LinkGeneric 05/2023 - 08/2012
2	evolocumabIBA 01/2022 - 06/2014
2	Antisense OligonucleotidesIBA 10/2020 - 01/2020
2	ISIS 304801IBA 10/2020 - 01/2019
2	Scavenger Receptors (Scavenger Receptor)IBA 11/2016 - 08/2003
2	Adenosine Triphosphate (ATP)IBA 11/2016 - 01/2006
2	HDL3 LipoproteinsIBA 01/2016 - 08/2003
2	omega-Chloroacetophenone (Mace)IBA 03/2014 - 10/2005
2	Niacin (Nicotinic Acid)FDA LinkGeneric 09/2010 - 06/2010
2	Transaminases (Aminotransferases)IBA 02/2010 - 07/2008
2	Rosiglitazone (Avandia)FDA Link 02/2010 - 07/2008
2	Blood Glucose (Blood Sugar)IBA 10/2008 - 06/2006
2	Fluvastatin FDA Link 10/2005 - 07/2003
2	Matrix Metalloproteinases (MMPs)IBA 02/2004 - 07/2003
1	DNA (Deoxyribonucleic Acid)IBA 01/2023

Therapy/Procedure

39	Therapeutics 03/2024 - 05/2002
13	Blood Component Removal (Apheresis) 01/2021 - 05/2002
5	Secondary Prevention 12/2022 - 06/2010
2	Drug Therapy (Chemotherapy) 10/2018 - 09/2014
1	Investigational Therapies (Experimental Therapy) 10/2023